The benchmark indices witnessed mild selling pressure amid range-bound trading on July 21, though the market breadth remained mildly positive. About 1,557 shares advanced, compared with 1,415 shares that declined, on the NSE. The market is likely to remain range-bound with a negative bias, while participants continue to monitor geopolitical tensions and crude oil prices. Below are some short-term ...

Let's catch up on the latest news from the stock market. From significant investments to major deals, quarterly earnings, and acquisitions, here’s a quick look at which stocks will be in focus in today's trade:Results TodayDr Reddy's Laboratories, Nestle India, Eternal, IndusInd Bank, CSB Bank, Adani Green Energy, Adani Power, Bharat Petroleum Corporation, Hindustan Petroleum Corporation, JSW En...

Shares of Havells India rose 0.68% to Rs 1,195.40 on Monday after Anand Rathi maintained its Buy rating on the stock, while lowering its target price to Rs 1,379 from Rs 1,447 earlier. The revised target implies an upside of around 15% from the current market price.The brokerage said Havells delivered a healthy Q1 FY27 performance, with consolidated revenue rising 19.5% year-on-year to Rs 65 billi...

Bank Nifty fell 1.6% on June 20 after heavyweight private banks declared mixed June quarter results.Shares of HDFC Bank fell 5% on June 20 after analysts flagged a sharper-than-expected decline in margins, overshadowing steady loan growth and stable asset quality in the lender's June-quarter results. The top private lender reported a modest 5% rise in the June quarter profit over the weekend.At 9:...

Shares of Emcure Pharmaceuticals rose 2.99% to Rs 1,836.50 on Monday after Motilal Oswal initiated coverage on the stock with a Buy rating and a target price of Rs 2,260, implying a potential upside of 23% from the current market price.Motilal Oswal said, "Emcure is implementing efforts to enhance differentiated offerings to both DF and international markets through its own R&D and acquired produc...